Wellington Biomedical Innovation Master Investors (Cayman) II L.P. - Significant Ownership

Signature - Title
Ihsan Speede - Authorized Person
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Wellington Biomedical Innovation Master Investors (Cayman) II L.P..

Significant Ownership of Wellington Biomedical Innovation Master Investors (Cayman) II L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MBX MBX Biosciences Common Stock 4.5% $35.3M 2.02M Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. Sep 30, 2025

Schedules 13D/G Reported by Wellington Biomedical Innovation Master Investors (Cayman) II L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.